Neuroscience News at Yale

A team at Yale, led by Martin Schwartz, PhD, Robert W. Berliner Professor of Medicine (cardiology), has identified a protein that helps your body sense and respond to changes in this shear stress.

To better understand the impact of NIH funding, U.S. Sen. Richard Blumenthal visited Yale School of Medicine for a tour of neuroscience lab facilities and a discussion with neuroscience researchers.

Rachel Bandler, MD, PhD, a third-year resident in the Yale Department of Psychiatry, has been selected to receive the 2024 National Institute of Mental Health (NIMH) Outstanding Resident Award.

Scientists at Yale have developed drugs that could help Alzheimer's patients. Today, the Neuroscience, Psychiatry, and Neurosurgery departments showcase their research during this Alzheimer's and Brain Awareness Month.

Philip Corlett, PhD; Jane Taylor, PhD; and Summer Thompson, PhD, are co-authors of a study in Cell Reports that uncovered how one specific region of the brain might causally provoke feelings of paranoia.

A new study offers insights into the pathologies underlying Alzheimer’s disease and mental illnesses such as schizophrenia.

Amy Arnsten, PhD, Albert E. Kent Professor of Neuroscience and Professor of Psychology; Kristen Brennand, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry; Philip Corlett, PhD, associate professor of psychiatry; and David Glahn, PhD, professor adjunct of psychiatry, were invited to speak at the 2024 Schizophrenia and Related Disorders course at Cold Spring Harbor Laboratory on Long Island in June.

The program will advance innovative research, and help facilitate the sharing of ideas, data, and knowledge to drive biomedical progress, therapeutics, and cures focused on combatting Alzheimer’s disease and related dementias.